News
George Medicines, a UK biopharma focused on cardiometabolic diseases, has entered into an exclusive licensing and supply ...
Every experienced patent attorney knows what is written below is true, but if you want the quiet parts to be spoken loudly, keep reading. This article isn’t revolutionary, but it screams a truth ...
Earlier today, a filing made by attorneys from both the U.S. Department of Justice, Antitrust Division, and the United States Patent & Trademark Office (USPTO) was filed that suggests that the ...
The fostrox plus Lenvima combination patent provides protection and market exclusivity until April 2041. “This Notice of Allowance for the fostrox plus lenvatinib combination is, together with the ...
Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.
The patent application, if approved, will strengthen Bone Biologics’ intellectual property portfolio and support the Company’s strategic plan to advance the clinical development program.
Patent supports the Company’s broader mission to advance minimally invasive, nerve-focused treatments across high-need indications Strengthens strategic position in a multi-billion-dollar market ...
Lutron Electronics has been ordered to pay millions of dollars in connection with a lengthy patent infringement case over window shade brackets.
As global patent litigation escalates, Taiwan's leading tech firms are coming under increasing fire. In 2024, several Taiwanese networking equipment manufacturers were blindsided by Huawei's ...
Apple and Qualcomm sought to transfer the patent troll case filed by Red Rock in 2021 to California, but their appeals have been denied by the U.S. District Judge and the Federal Circuit Court.
European Unitary Patent EP4117446 Validated - Lobe Sciences secures patent protection in 17 EU member states for its DHA and egg yolk-based composition designed to manage Sickle Cell Disease ...
Samsung Electronics on Wednesday won a ruling from London's High Court in its attempt to get an interim licence to use ZTE's patents, in the English leg of the firms' global licensing dispute over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results